Overview Multiple Dose Ethnobridging PK Study in Healthy Subjects Status: Completed Trial end date: 2019-02-13 Target enrollment: Participant gender: Summary A Phase 1, double blind, placebo controlled, 4 cohort, multiple dose study in healthy adult Japanese and Caucasian subjects. Phase: Phase 1 Details Lead Sponsor: Theravance Biopharma